Italy’s venture capital firmĀ Innogest Capital sgr join a 34.5 million euro investment round for Spanish medtech companyĀ MedLumics, cardiac device company specializing in optically guided minimally invasive instruments (seeĀ here the press release).This is the biggest deal ever in this sector in Spain.
The investment round was led byĀ Edmond de Rothschild Investment Partners, joined byĀ Innogest,Ā Seroba Life SciencesĀ and a strategic investor, also joined by existing shareholdersĀ Ysios Capital Partners andĀ Caixa Capital Risc. Following the deal, EdR’s partner Olivier Litzka, Innogest’s partnerĀ Claudio RumazzaĀ and Seroba’s partnerĀ James GreenĀ will become members of MedLumics board of directors.
The new cash will be used to help advance the product and clinical development of the companyās AblaView catheter, intended for the treatment of atrial fibrillation and other arrhythmias.
